Evaluation of Plantago?Marigold and honey (traditional medicine product) with placebo on dermatitis caused by radiotherapy in cancer patients

Phase 3

Conditions: Radiodermatitis, unspecified
radiation therapy-induced dermatitis.
L58.9

Registration Number: IRCT20170404033202N11

Lead Sponsor: Sabzevar University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 84

Inclusion Criteria

Consent to participate in the study
Mental and intellectual health
Radiotherapy candidate
Staying in Bezvar and suburbs (all meetings should be held in Bezvar)
Age range 45-70 years
Absence of underlying chronic disease: dermatology, lupus, active scleroderma, underlying allergy, diabetes, and chronic kidney disease
No smoking, drugs and alcohol

Exclusion Criteria

People who have changed their place of residence since the middle of the study
Do not agree to continue participating in the project from the middle of the study
suffer severe complications from radiotherapy.
Changing the patient's treatment method from the middle of the treatment process
Failure to use plan drugs
have allergies to study drugs

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dermatitis. Timepoint: Day 0 (day of starting radiation therapy and start of intervention) and days 7-14-21 after the treatment and one month after the end of the treatment to check acute dermatitis and 3 months after the end of treatment to check sub-acute dermatitis. Method of measurement: CTCAE v5.0.

Secondary Outcome Measures

Name	Time	Method
Itching. Timepoint: (From start of intervention) to day 7-21-28 (from the start of radiotherapy once a week). Method of measurement: self expression.;Erythema. Timepoint: (From start of intervention) to day 7-21-28 (from the start of radiotherapy once a week). Method of measurement: view.